跳至主要内容
临床试验/NL-OMON55566
NL-OMON55566已完成不适用

A multi-center randomized controlled study of primary prevention of esophageal variceal bleeding in cirrhotic patients treated with HVPG-guided beta- blocker therapy or standard heart rate-guided beta-blocker therapy. - PORTHOS trial

eids Universitair Medisch Centrum0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Liver cirrhosis
  • Esophageal varices >=5 mm, no prior variceal bleeding
  • Patient age 18 years or older

排除标准

  • Contraindications to beta-blocker therapy
  • Prior variceal hemorrhage
  • Esophageal varices in the absence of liver cirrhosis
  • Intermediate, advanced or terminal stage hepatocellular carcinoma (BCLC stage
  • Refractory ascites
  • Hepatorenal syndrome
  • Prior treatment or prophylaxis for esophageal varices or esophageal variceal
  • bleedings (propranolol use, TIPS, endoscopic bandligation, endoscopic
  • sclerotherapy)

研究者

相似试验